4//SEC Filing
Seltzer Stacey Denenberg 4
Accession 0000899243-20-014609
CIK 0001631650other
Filed
May 28, 8:00 PM ET
Accepted
May 29, 7:12 PM ET
Size
7.7 KB
Accession
0000899243-20-014609
Insider Transaction Report
Form 4
Seltzer Stacey Denenberg
Director
Transactions
- Award
Stock Option (right to buy)
2020-05-27+15,398→ 15,398 totalExercise: $17.11Exp: 2030-05-26→ Common Stock (15,398 underlying) - Award
Common Stock, $0.0001 par value
2020-05-27+7,840→ 18,061 total
Footnotes (2)
- [F1]These shares represent restricted stock units ("RSUs") and will be settled in common stock upon vesting. The RSUs vest on the earlier of (i) the first anniversary of the grant date or (ii) the date of the 2021 Annual Meeting of the Issuer's stockholders, assuming continuous service as a director until such vesting date.
- [F2]The shares subject to the option will vest and become exercisable as to 100% of the total number of shares subject to the option on the earlier of (i) the first anniversary of the grant date or (ii) the date of the 2021 Annual Meeting of the Issuer's stockholders, assuming continuous service as a director until such vesting date.
Documents
Issuer
Aimmune Therapeutics, Inc.
CIK 0001631650
Entity typeother
Related Parties
1- filerCIK 0001648895
Filing Metadata
- Form type
- 4
- Filed
- May 28, 8:00 PM ET
- Accepted
- May 29, 7:12 PM ET
- Size
- 7.7 KB